| As Of | Filing | | Doc. | | Page | | Title | Docs. |
|---|
| | |  |
| 5/11/23 | | DEF 14A | | | | 1 | | A Letter from the Chair of the Compensation and Human Capital Committee | 1 |
| | | | | | 1 | | Advisory Approval of Executive Compensation | 1 |
| | | | | | 1 | | Advisory Vote on the Frequency of Future Advisory Votes on Executive Compensation | 1 |
| | | | | | 1 | | Approval of An Amendment and Restatement of the 1996 Stock Incentive Plan | 1 |
| | | | | | 1 | | Audit-Related Fees, Tax Fess and All Other Fees | 1 |
| | | | | | 1 | | Board of Directors and Corporate Governance, The | 1 |
| | | | | | 1 | | Certain Relationships and Related Transactions | 1 |
| | | | | | 1 | | Compensation and Human Capital Committee Report | 1 |
| | | | | | 1 | | Compensation Discussion and Analysis | 1 |
| | | | | | 1 | | Compensation Objectives | 1 |
| 5/25/23 | | 10-Q | | | | 1 | | Consolidated Balance Sheets at April 30, 2023, January 31, 2023 and April 30, 2022 | 1 |
| 3/26/24 | | 10-K | | | | 1 | | Consolidated Balance Sheets at January 31, 2024 and 2023 | 1 |
| 8/24/23 | | 10-Q | | | | 1 | | Consolidated Balance Sheets at July 31, 2023, January 31, 2023 and July 31, 2022 | 1 |
| 11/30/23 | | 10-Q | | | | 1 | | Consolidated Balance Sheets at October 31, 2023, January 31, 2023 and October 31, 2022 | 1 |
| 3/26/24 | | 10-K | | | | 1 | | Consolidated Statements of Cash Flows for the fiscal years ended January 31, 2024, 2023 and 2022 | 1 |
| 11/30/23 | | 10-Q | | | | 1 | | Consolidated Statements of Cash Flows for the nine months ended October 31, 2023 and October 31, 2022 | 1 |
| 8/24/23 | | 10-Q | | | | 1 | | Consolidated Statements of Cash Flows for the six months ended July 31, 2023 and July 31, 2022 | 1 |
| 5/25/23 | | 10-Q | | | | 1 | | Consolidated Statements of Cash Flows for the three months ended April 30, 2023 and April 30, 2022 | 1 |
| 3/26/24 | | 10-K | | | | 1 | | Consolidated Statements of Changes in Equity for the fiscal years ended January 31, 2024, 2023 and 2022 | 1 |
| | | | | | 1 | | Consolidated Statements of Comprehensive Income (Loss) for the fiscal years ended January 31, 2024, 2023 and 2022 | 1 |
| 11/30/23 | | 10-Q | | | | 1 | | Consolidated Statements of Comprehensive Income (Loss) for the three and nine months ended October 31, 2023 and October 31, 2022 | 1 |
| 8/24/23 | | 10-Q | | | | 1 | | Consolidated Statements of Comprehensive Income (Loss) for the three and six months ended July 31, 2023 and July 31, 2022 | 1 |
| 5/25/23 | | 10-Q | | | | 1 | | Consolidated Statements of Comprehensive Income (Loss) for the three months ended April 30, 2023 and April 30, 2022 | 1 |
| 3/26/24 | | 10-K | | | | 1 | | Consolidated Statements of Operations for the fiscal years ended January 31, 2024, 2023 and 2022 | 1 |
| 11/30/23 | | 10-Q | | | | 1 | | Consolidated Statements of Operations for the three and nine months ended October 31, 2023 and October 31, 2022 | 1 |
| 8/24/23 | | 10-Q | | | | 1 | | Consolidated Statements of Operations for the three and six months ended July 31, 2023 and July 31, 2022 | 1 |
| 5/25/23 | | 10-Q | | | | 1 | | Consolidated Statements of Operations for the three months ended April 30, 2023 and April 30, 2022 | 1 |
| 11/30/23 | | 10-Q | | | | 1 | | Controls and Procedures | 3 |
| 5/11/23 | | DEF 14A | | | | 1 | | Director Compensation | 1 |
| | | | | | 1 | | Election of Directors | 1 |
| | | | | | 1 | | Equity Compensation Plan Information | 1 |
| | | | | | 1 | | Executive Compensation | 1 |
| | | | | | 1 | | Executive Officers | 1 |
| 11/30/23 | | 10-Q | | | | 1 | | Exhibits | 3 |
| 5/11/23 | | DEF 14A | | | | 1 | | Fiscal 2023 Executive Compensation Components | 1 |
| | | | | | 1 | | Fiscal 2023 Highlights | 1 |
| | | | | | 1 | | Grants of Plan-Based Awards in Fiscal 2023 | 1 |
| 11/30/23 | | 10-Q | | | | 1 | | Legal Proceedings | 3 |
| | | | | | 1 | | Management's Discussion and Analysis of Financial Condition and Results of Operations | 3 |
| 5/11/23 | | DEF 14A | | | | 1 | | Nonqualified Deferred Compensation | 1 |
| 3/26/24 | | 10-K | | | | 1 | | Notes to Consolidated Financial Statements | 4 |
| 5/11/23 | | DEF 14A | | | | 1 | | Option Exercises and Stock Vested During Fiscal 2023 | 1 |
| 11/30/23 | | 10-Q | | | | 1 | | Other Information | 3 |
| 5/11/23 | | DEF 14A | | | | 1 | | Other Matters | 1 |
| | | | | | 1 | | Outstanding Equity Awards at Fiscal 2023 Year-End | 1 |
| | | | | | 1 | | Pay Ratio Disclosure | 1 |
| | | | | | 1 | | Pay Versus Performance | 1 |
| | | | | | 1 | | Potential Payments on Termination or Change in Control | 1 |
| 11/30/23 | | S-8 | | | | 1 | | Powers of Attorney (included on signature pages of this Part I) | 1 |
| 5/11/23 | | DEF 14A | | | | 1 | | Proposal 1 -- Election of Directors | 1 |
| | | | | | 1 | | Proposal 2 -- Ratification of Appointment of Accountants | 1 |
| | | | | | 1 | | Proposal 3 -- Advisory Approval of Executive Compensation | 1 |
| | | | | | 1 | | Proposal 4 -- Advisory Vote on the Frequency of Future Advisory Votes on Executive Compensation | 1 |
| | | | | | 1 | | Proposal 5 -- Approval of An Amendment and Restatement of the 1996 Stock Incentive Plan | 1 |
| 11/30/23 | | 10-Q | | | | 1 | | Quantitative and Qualitative Disclosures About Market Risk | 3 |
| 5/11/23 | | DEF 14A | | | | 1 | | Ratification of Appointment of Accountants | 1 |
| 3/26/24 | | 10-K | | | | 1 | | Report of Independent Registered Public Accounting Firm (PCAOB ID 238 ) | 1 |
| 5/11/23 | | DEF 14A | | | | 1 | | Report of the Audit Committee of the Board of Directors | 1 |
| 11/30/23 | | 10-Q | | | | 1 | | Risk Factors | 3 |
| 5/11/23 | | DEF 14A | | | | 1 | | Role of the Compensation and Human Capital Committee | 1 |
| | | | | | 1 | | Security Ownership of Certain Beneficial Owners and Management | 1 |
| | | | | | 1 | | Setting Executive Compensation | 1 |
| 11/30/23 | | 10-Q | | | | 1 | | Signature | 3 |
| 5/11/23 | | DEF 14A | | | | 1 | | Some Questions You May Have Regarding This Proxy Statement | 1 |
| | | | | | 1 | | Summary Compensation Table for Fiscal 2023 | 1 |
| | | | | | 1 | | Table of Contents | 1 |
| | | | | | 1 | | Tax and Accounting Implications | 1 |
| | | | | | 1 | | The Board of Directors and Corporate Governance | 1 |
| 11/30/23 | | 10-Q | | | | 1 | | Unregistered Sales of Equity Securities and Use of Proceeds | 3 |
| 3/26/24 | | 10-K | | | | 1 | | Valuation and Qualifying Accounts for the fiscal years ended January 31, 2024, 2023 and 2022 | 1 |
